INVA vs. JNJ
INVA (Innoviva, Inc.) and JNJ (Johnson & Johnson) are both stocks. Both are in the Healthcare sector — INVA in Biotechnology, JNJ in Drug Manufacturers - General. Over the past 10 years, INVA returned 7.00%/yr vs 10.06%/yr for JNJ. At a 0.24 correlation, their price movements are largely independent.
Performance
INVA vs. JNJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INVA achieves a 11.71% return, which is significantly lower than JNJ's 13.43% return. Over the past 10 years, INVA has underperformed JNJ with an annualized return of 7.00%, while JNJ has yielded a comparatively higher 10.06% annualized return.
INVA
- 1D
- -0.84%
- 1M
- -2.45%
- YTD
- 11.71%
- 6M
- 6.33%
- 1Y
- 3.48%
- 3Y*
- 18.85%
- 5Y*
- 12.47%
- 10Y*
- 7.00%
JNJ
- 1D
- -0.26%
- 1M
- 5.50%
- YTD
- 13.43%
- 6M
- 16.43%
- 1Y
- 53.49%
- 3Y*
- 16.56%
- 5Y*
- 10.04%
- 10Y*
- 10.06%
INVA vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INVA Innoviva, Inc. | 11.71% | 15.22% | 8.17% | 21.06% | -23.19% | 39.23% | -12.50% | -18.85% | 22.97% | 32.62% |
JNJ Johnson & Johnson | 13.43% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 16.22% | -5.13% | 24.43% |
Correlation
The correlation between INVA and JNJ is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Oct 6, 2004 | 0.24 |
Fundamentals
INVA:
$1.89B
JNJ:
$567.68B
INVA:
$5.94
JNJ:
$8.65
INVA:
3.76
JNJ:
26.85
INVA:
0.02
JNJ:
0.89
INVA:
4.47
JNJ:
5.86
INVA:
1.31
JNJ:
6.99
INVA:
$424.12M
JNJ:
$96.36B
INVA:
$323.16M
JNJ:
$66.60B
INVA:
$438.91M
JNJ:
$31.62B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INVA vs. JNJ — Risk / Return Rank
INVA
JNJ
INVA vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innoviva, Inc. (INVA) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| INVA | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.07 | ||
| Sortino ratioReturn per unit of downside risk | -4.20 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.57 | -0.52 |
| Calmar ratioReturn relative to maximum drawdown | 0.15 | 4.91 | -4.76 |
| Martin ratioReturn relative to average drawdown | 0.34 | 14.52 | -14.17 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| INVA | JNJ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.12 | 3.19 | -3.07 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.46 | 0.60 | -0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.21 | 0.55 | -0.34 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.05 | 0.54 | -0.49 |
Drawdowns
INVA vs. JNJ - Drawdown Comparison
The maximum INVA drawdown since its inception was -84.32%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for INVA and JNJ.
Loading charts...
Drawdown Indicators
| INVA | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.32% | -50.67% | -33.65% |
Max Drawdown (1Y)Largest decline over 1 year | -23.53% | -10.96% | -12.57% |
Max Drawdown (3Y)Largest decline over 3 years | -23.53% | -15.95% | -7.58% |
Max Drawdown (5Y)Largest decline over 5 years | -47.01% | -18.41% | -28.60% |
Max Drawdown (10Y)Largest decline over 10 years | -59.57% | -27.37% | -32.20% |
Current DrawdownCurrent decline from peak | -30.17% | -6.06% | -24.11% |
Average DrawdownAverage peak-to-trough decline | -44.65% | -11.88% | -32.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.21% | 3.70% | +6.51% |
Volatility
INVA vs. JNJ - Volatility Comparison
Innoviva, Inc. (INVA) has a higher volatility of 7.62% compared to Johnson & Johnson (JNJ) at 5.80%. This indicates that INVA's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INVA | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.62% | 5.80% | +1.82% |
Volatility (6M)Calculated over the trailing 6-month period | 16.91% | 12.41% | +4.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.81% | 16.87% | +11.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.28% | 16.87% | +10.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.89% | 18.47% | +15.42% |
Dividends
INVA vs. JNJ - Dividend Comparison
INVA has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 2.26%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
INVA Innoviva, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.12% |
JNJ Johnson & Johnson | 2.26% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
Financials
INVA vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Innoviva, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
INVA and JNJ have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INVA has higher volatility (7.62%) compared to JNJ (5.80%). In terms of maximum drawdown, INVA dropped -84.32% vs JNJ's -50.67%.
JNJ currently has the higher Sharpe Ratio (3.19 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INVA and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer